Ryo Nakayama

1.2k total citations
33 papers, 214 citations indexed

About

Ryo Nakayama is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ryo Nakayama has authored 33 papers receiving a total of 214 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Ryo Nakayama's work include Hormonal and reproductive studies (12 papers), Estrogen and related hormone effects (7 papers) and Prostate Cancer Treatment and Research (6 papers). Ryo Nakayama is often cited by papers focused on Hormonal and reproductive studies (12 papers), Estrogen and related hormone effects (7 papers) and Prostate Cancer Treatment and Research (6 papers). Ryo Nakayama collaborates with scholars based in Japan, United States and Spain. Ryo Nakayama's co-authors include K Sudo, Keiji Yoshida, O Yoshida, K Oishi, K Okada, Kentaro Hiraga, Tsuneo Masaki, Takuichi Miki, Iwao Yamazaki and Kunio Shiota and has published in prestigious journals such as Endocrinology, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Ryo Nakayama

30 papers receiving 194 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryo Nakayama Japan 9 83 67 49 41 32 33 214
Béatrice Sente Belgium 8 203 2.4× 150 2.2× 77 1.6× 51 1.2× 99 3.1× 8 347
Dixie W. Frederiksen United States 9 114 1.4× 175 2.6× 36 0.7× 24 0.6× 19 0.6× 13 334
W. von Rechenberg Germany 9 119 1.4× 65 1.0× 47 1.0× 47 1.1× 128 4.0× 15 282
Carl Turgeon Canada 8 197 2.4× 99 1.5× 132 2.7× 17 0.4× 30 0.9× 8 318
Pentti Tuohimaa Finland 10 53 0.6× 98 1.5× 121 2.5× 15 0.4× 124 3.9× 15 340
J. Gaughan United Kingdom 6 79 1.0× 129 1.9× 274 5.6× 19 0.5× 154 4.8× 7 415
Ellen Reusch United States 8 207 2.5× 90 1.3× 72 1.5× 22 0.5× 143 4.5× 12 317
Yigal Farkash Israel 8 173 2.1× 241 3.6× 179 3.7× 10 0.2× 97 3.0× 11 496
Pradeep Kayampilly United States 9 46 0.6× 137 2.0× 36 0.7× 6 0.1× 84 2.6× 14 298
Claudio Gómez Colombia 11 23 0.3× 183 2.7× 24 0.5× 18 0.4× 14 0.4× 38 314

Countries citing papers authored by Ryo Nakayama

Since Specialization
Citations

This map shows the geographic impact of Ryo Nakayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Nakayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Nakayama more than expected).

Fields of papers citing papers by Ryo Nakayama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryo Nakayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Nakayama. The network helps show where Ryo Nakayama may publish in the future.

Co-authorship network of co-authors of Ryo Nakayama

This figure shows the co-authorship network connecting the top 25 collaborators of Ryo Nakayama. A scholar is included among the top collaborators of Ryo Nakayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryo Nakayama. Ryo Nakayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Takemoto, K. K., Ryo Nakayama, Koichi Fujimoto, et al.. (2024). In vitro and in vivo activities of KSP-1007, a broad-spectrum inhibitor of serine- and metallo-β-lactamases, in combination with meropenem against carbapenem-resistant Gram-negative bacteria. Antimicrobial Agents and Chemotherapy. 68(6). e0160223–e0160223. 4 indexed citations
3.
Watanabe, Kazuhiro, et al.. (2019). Trousseau's syndrome manifesting as multiple cerebral infarctions caused by bladder cancer. Urology Case Reports. 24. 100884–100884. 1 indexed citations
4.
Katagiri, Akiyoshi, et al.. (2018). Hypercalcemia associated with lymph node metastasis following radical cystectomy for bladder cancer. IJU Case Reports. 1(1). 25–28. 4 indexed citations
5.
Fujita, Katsuya, Masaya Mori, Ryo Nakayama, et al.. (2015). DSR-71167, a Novel Mineralocorticoid Receptor Antagonist with Carbonic Anhydrase Inhibitory Activity, Separates Urinary Sodium Excretion and Serum Potassium Elevation in Rats. Journal of Pharmacology and Experimental Therapeutics. 354(1). 2–9. 6 indexed citations
6.
Tokumoto, Toshinobu, Mika Tokumoto, Tatsuya Fukuda, et al.. (2012). Characterization of multiple membrane progestin receptor (mPR) subtypes from the goldfish ovary and their roles in the induction of oocyte maturation. General and Comparative Endocrinology. 177(1). 168–176. 30 indexed citations
7.
Okada, K, et al.. (1988). Study of the effect of an anti-androgen (Oxendolone) on experimentally induced canine prostatic hyperplasia. Urological Research. 16(2). 67–72. 14 indexed citations
8.
Okada, K, et al.. (1988). Study of the effect of an anti-androgen (Oxendolone) on experimentally induced canine prostatic hyperplasia. Urological Research. 16(2). 73–78. 23 indexed citations
9.
Shiota, Kunio, et al.. (1984). In vitro thyrotrophin release with thyrotrophin-releasing hormone and an analogue, DN-1417. European Journal of Endocrinology. 106(1). 71–78. 6 indexed citations
10.
Sudo, Katsuichi, et al.. (1984). Radioimmunoassay for serum levels of an antiandrogen TSAA-291 (Oxendolone) in rats.. Journal of Pharmacobio-Dynamics. 7(6). 378–384. 1 indexed citations
11.
12.
13.
Sudo, K, Keiji Yoshida, & Ryo Nakayama. (1982). Specific interaction of radioactive anti-androgen TSAA-291 with androgen receptor in rat prostates. European Journal of Endocrinology. 100(3). 473–480. 3 indexed citations
14.
15.
Nakayama, Ryo, et al.. (1979). I. ANTI-ANDROGENIC EFFECTS OF A NEW STEROID TSAA-291 (16β-ETHYL-17β-HYDROXY-4-OESTREN-3-ONE) AND ITS DERIVATIVES. European Journal of Endocrinology. 92(3_Supplb). S2–S23. 6 indexed citations
16.
17.
Sudo, K, et al.. (1979). V. EFFECTS OF THE ANTI-ANDROGEN TSAA-291 ON THE ANDROGEN-RECEPTOR COMPLEX FORMATION FROM [3H]TESTOSTERONE IN RAT VENTRAL PROSTATES. European Journal of Endocrinology. 92(3_Supplb). S67–S81. 5 indexed citations
18.
Goto, Giichi, et al.. (1978). Synthesis and antiandrogenic activity of 16.BETA.-substituted-17.BETA.-hydroxysteroids.. Chemical and Pharmaceutical Bulletin. 26(6). 1718–1728. 18 indexed citations
19.
Rippel, R. H., E. S. Johnson, W. F. White, et al.. (1973). Ovulating and LH-Releasing Activity of a Highly Potent Analog of Synthetic Gonadotropin-Releasing Hormone1. Endocrinology. 93(6). 1449–1452. 17 indexed citations
20.
Yamazaki, Iwao & Ryo Nakayama. (1972). Comparison of Ovulation-inducing Effect between Estrogen and Progestin in the Ovulation-Blocked Rat by Chlorpromazine. Endocrinologia Japonica. 19(2). 175–183. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Béatrice Sente Breakdown of academic impact, for papers by Dixie W. Frederiksen Breakdown of academic impact, for papers by W. von Rechenberg Breakdown of academic impact, for papers by Carl Turgeon Breakdown of academic impact, for papers by Pentti Tuohimaa Breakdown of academic impact, for papers by J. Gaughan Breakdown of academic impact, for papers by Ellen Reusch Breakdown of academic impact, for papers by Yigal Farkash Breakdown of academic impact, for papers by Pradeep Kayampilly Breakdown of academic impact, for papers by Claudio Gómez
Rankless by CCL
2026